Seventeen proteins, most of which are lung damage and inflammation specific, repeatedly showed differential regulation in the nanomaterial-exposed samples compared with the control group. Based
on the proteins identified, the major observed effect of nanomaterial exposure is an inflammatory response. Macrophage-capping protein, IgE-dependent histamine-releasing factor, and heat shock 27 kDa protein 1, well-known mediators of inflammation, were upregulated. This is in accordance with the results obtained from the inflammatory factor in BALF Epacadostat and lung pathological analysis. Glutathione transferase, glutathione S-transferase alpha-5, ubiquinol-cytochrome-c reductase, and glutathione peroxidase 1, all related to oxidative stress, were
upregulated in the groups exposed to the three nanomaterials, indicating that the nanoparticles could induce the oxidative damage in lung tissue, which consumed considerable glutathione peroxidase to make the three enzymes of glutathione transferase, glutathione S-transferase alpha-5, and ubiquinol-cytochrome-c reductase accumulation to destroy the balance of oxidative and anti-oxidation. ATP synthase GDC-0994 in vitro subunit alpha, MycoClean Mycoplasma Removal Kit ADP/ATP transport protein, inward rectifier potassium channel
protein IRK3, and Ca2+-transporting ATPase, all associated with ATP synthesis, were downregulated in the groups exposed to the three nanomaterials, indicating that the histiocytes of the lung were short of energy. Intratracheal instillation of nanomaterials injured lungs and influenced food intake, even nutrient absorption and metabolism, which was reflected in the decreased weight of nanomaterial-exposed rats. These 17 different proteins were in concert with the results obtained from the biochemical assays in BALF which showed obvious diversity in oxidative and inflammatory damage of the three nanomaterials. The discovery of transgelin 2 in the MALDI-TOF data provoked our interest, which also demonstrated an advantage to a top-down proteomics approach. Transgelin 2 is a marker of cell differentiation. Lung fibroblasts (LFs) only exist in selleck kinase inhibitor normal lung tissue. After lung damage, LFs differentiate into myofibroblasts (MFs), which is identified by transgelin 2 in the cytoplasm.